Search research articles
Contact Us
Filters
Showing results (121-130 of 153) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2000
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
A D Roth, R Maibach, G Martinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group
M Colleoni, M Bonetti, A S Coates, et al.
British Journal of Cancer
|
September 23, 1998
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
J Bernhard, C Hürny, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer
A Ravaioli, F Monti, M M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII
A Wallgren, M Bonetti, R D Gelber, et al.
Lancet (London, England)
|
June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
S Aebi, S Gelber, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
O Pagani, A O'Neill, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Human Genetics
|
October 6, 1998
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus
K K Kidd, B Morar, C M Castiglione, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 153) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2000
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
A D Roth, R Maibach, G Martinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group
M Colleoni, M Bonetti, A S Coates, et al.
British Journal of Cancer
|
September 23, 1998
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
J Bernhard, C Hürny, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer
A Ravaioli, F Monti, M M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII
A Wallgren, M Bonetti, R D Gelber, et al.
Lancet (London, England)
|
June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
S Aebi, S Gelber, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
O Pagani, A O'Neill, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Human Genetics
|
October 6, 1998
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus
K K Kidd, B Morar, C M Castiglione, et al.
Page
of 16